IL2 and Hepatic fibrosis: This finding qualifies IL-2 as a non-HCV-specific marker of liver necro-inflammation and corroborates a pathogenetic role of the activation of the IL-2 pathway in the progression of liver fibrosis, regardless of the nature of the primary insult (viral vs. metabolic), as previously supported by indirect evidence [37,38].